Share Email Print

Proceedings Paper

Preferential heating using transurethral thermoablation (T3) improves clinical results
Author(s): Ernest W. Ramsey; Paul D. Miller; Keith Parsons
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Transurethral microwave thermotherapy (TUMT) has been widely reported for the treatment of benign prostatic hyperplasia (BPH) but with variable results. This is likely due to the inability to develop and maintain high intraprostatic temperatures. The T3 device has a preferential heating pattern which prevents shutdowns as a result of rectal heating thus allowing continuous energy delivery throughout the therapy. High temperatures greater than 70 degrees Celsius are maintained resulting in extensive coagulative necrosis in the transitional zone. Treatment was performed in an outpatient clinic using topical anaesthesia with occasional low dose I.V. analgesia. One hundred and fifty-four patients have been treated in 3 centers using a similar protocol. Inclusion criteria required an AUA symptom score greater than or equal to 9 and a peak uroflow rate less than or equal to 12 ml/sec. Mean prostate size was 40.6 cc. One hundred and eighteen patients have been followed for at least 12 months, and 58 for 24 months. AUA symptom score decreased from a mean of 19.8 to 8.9 (12 M), and 7.6 (24 M). Improvement was seen in all 7 symptoms evaluated. Peak flow rates increased from a mean of 9.3 to 13.4 (12 M), and 13.1 (24 M). Improvement in symptom score and peak flow was observed across all prostate sizes. By 2 years, 15 patients had dropped out of the study, 8 for alternative treatment (6 TURP, 1 bladder neck incision, 1 urethrotomy) and 7 for administrative or other reasons. Treatment with the T3 device provides excellent improvement in symptoms, flow rates and patients satisfaction. T3 fulfills the criteria for an effective, minimally invasive, outpatient treatment for symptomatic BPH.

Paper Details

Date Published: 22 May 1997
PDF: 10 pages
Proc. SPIE 2970, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems VII, (22 May 1997); doi: 10.1117/12.275077
Show Author Affiliations
Ernest W. Ramsey, Health Sciences Ctr. (Canada)
Paul D. Miller
Keith Parsons

Published in SPIE Proceedings Vol. 2970:
Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems VII
R. Rox Anderson M.D.; Harvey Lui M.D.; Michail M. Pankratov; Kenneth Eugene Bartels D.V.M.; Gerhard J. Mueller; Graham M. Watson M.D.; Reza S. Malek M.D.; Lawrence S. Bass M.D.; Lloyd P. Tate V.D.M.; Hans-Dieter Reidenbach; Kenneth Eugene Bartels D.V.M.; R. Rox Anderson M.D.; Lawrence S. Bass M.D.; Aaron P. Perlmutter M.D.; Kenton W. Gregory M.D.; David M. Harris; David M. Harris; Harvey Lui M.D.; Reza S. Malek M.D.; Gerhard J. Mueller; Michail M. Pankratov; Aaron P. Perlmutter M.D.; Hans-Dieter Reidenbach; Lloyd P. Tate V.D.M.; Graham M. Watson M.D., Editor(s)

© SPIE. Terms of Use
Back to Top